Inactive Instrument

IXICO PLC Share Price London S.E.

Equities

GB00BCLY7L40

Biotechnology & Medical Research

Financials

Sales 2024 * 52L 66.24L 55Cr Sales 2025 * - Capitalization 33.85L 43.12L 36Cr
Net income 2024 * -20L -25.48L -21Cr Net income 2025 * - EV / Sales 2024 * 0.38 x
Net cash position 2024 * 14L 17.83L 15Cr Net cash position 2025 * - 0 0 EV / Sales 2025 * -
P/E ratio 2024 *
-1.27 x
P/E ratio 2025 *
-
Employees -
Yield 2024 *
-
Yield 2025 *
-
Free-Float 51.17%
More Fundamentals * Assessed data
Dynamic Chart
Managers TitleAgeSince
Chief Executive Officer 63 06/17/06
Director of Finance/CFO 47 31/19/31
Chairman 59 14/13/14
Members of the board TitleAgeSince
Chairman 59 14/13/14
Director/Board Member 49 16/16/16
Director/Board Member 60 05/23/05
More insiders
IXICO plc is a United Kingdom-based medical imaging advanced analytics company. The Company is engaged in delivering insights in neuroscience to help transform the advancement of investigational therapies for neurological diseases, such as Huntington's disease, Parkinson's disease and Alzheimer's disease. It advances medicine and human health by turning data into clinically meaningful information, providing new insights in neuroscience by supporting pharmaceutical companies across all phases of central nervous system (CNS) clinical research. Its services include the collection, analysis, management, and reporting on data generated in the course of a clinical study. Its data platforms include TrialTracker and Assessa. The TrialTracker platform provides a secure and compliant environment for the collection, analysis and interpretation of large image files and other data. Its neuroimaging biomarkers focus area includes Radiological Reads, Volumetric MRI, PET and SPECT, and Advanced MRI.
More about the company